These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8549363)

  • 1. Evaluation of clinical efficacy of antimicrobials in complicated urinary tract infections. Comparison of Japanese criteria with IDSA guidelines. Infectious Diseases Society of America.
    Kawada Y; Lee SE; Chen C; Limson BM; Chan P; Kongkanand A; Wudhikarn S; Tung KH; Rahardjo P; Saito I
    Drugs; 1995; 49 Suppl 2():362-4. PubMed ID: 8549363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs].
    Derevianko II; Lavrinova LN; Kudriashova EE
    Urologiia; 2003; (1):31-4. PubMed ID: 12621964
    [No Abstract]   [Full Text] [Related]  

  • 3. Levofloxacin in the treatment of urinary tract infections and prostatitis.
    Naber KG
    J Chemother; 2004 Apr; 16 Suppl 2():18-21. PubMed ID: 15255558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of the study on antibiotic resistance emergence among pathogens of community-acquired urinary tract infections in Moscow. Phase I].
    Sidorenko SV; Ivanov DV
    Antibiot Khimioter; 2005; 50(1):3-10. PubMed ID: 16302640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness and problems of the urinary tract infection criteria for evaluating drug efficacy for complicated urinary tract infections.
    Arakawa S; Tanaka K; Miura T; Shigemura K; Takenaka A; Matsui T; Kamidono S; Nakano Y; Fujisawa M
    J Infect Chemother; 2007 Oct; 13(5):279-84. PubMed ID: 17982714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National guideline for the management of prostatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
    Sex Transm Infect; 1999 Aug; 75 Suppl 1():S46-50. PubMed ID: 10616384
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections.
    Naber KG
    Int J Antimicrob Agents; 1999 May; 11(3-4):189-96; discussion 213-6. PubMed ID: 10394969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of complicated urinary tract infections in men and women.
    Kawada Y
    Infection; 1994; 22 Suppl 1():S55-7. PubMed ID: 8050798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on the treatment duration of an antibacterial agent in complicated urinary tract infections. Utility and recurrence after 14-day treatment by fleroxacin].
    Arakawa S; Takagi S; Matsumoto O; Kamidono S; Sengoku A; Hazama M; Yamazaki H; Hamami G; Okamoto Y; Tanaka H
    Jpn J Antibiot; 1991 Jul; 44(7):718-31. PubMed ID: 1909383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
    Hagiya H
    J Chemother; 2015 Feb; 27(2):124-5. PubMed ID: 25248022
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
    Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
    Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 13. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.
    Rugendorff EW
    Drugs; 1987; 34 Suppl 1():91-4. PubMed ID: 3481333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis.
    Redman R; Damiao R; Kotey P; Kaniga K; Davies T; Naber KG
    J Chemother; 2010 Dec; 22(6):384-91. PubMed ID: 21303745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin tromethamine in uncomplicated urinary tract infections: an epidemiological survey.
    Tempera G; Mirabile M; Mangiafico A; Caccamo M; Bonfiglio G
    J Chemother; 2004 Apr; 16(2):216-7. PubMed ID: 15216960
    [No Abstract]   [Full Text] [Related]  

  • 17. 3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.
    Raz R; Rozenfeld S
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2200-1. PubMed ID: 8878607
    [No Abstract]   [Full Text] [Related]  

  • 18. Ofloxacin vs. cotrimoxazole in patients with complicated urinary tract infections.
    Vellucci A; Bernardini G; Battaglia AM; Battaglia P
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):279-81. PubMed ID: 3496284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with the use of ofloxacin in infections of the upper and lower urinary tracts: demonstrations of the results of clinical trials].
    Liudvig G
    Antibiot Khimioter; 1996; 41(9):84-5. PubMed ID: 9005795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.
    Onrust SV; Lamb HM; Balfour JA
    Drugs; 1998 Nov; 56(5):895-928. PubMed ID: 9829160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.